Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by gebremeskelon Jul 25, 2019 11:47am
156 Views
Post# 29959410

RE:RE:UP

RE:RE:UPIt makes sense to be concerned about the share price when it has plunged to this level, at this stage of the game, seemingly to accommodate participants in the financing. Theralase is about to start treating patients in a phase 2 trial for what what looks to be an unprecedentedly safe and efficacious treatment for bladder cancer.

What's with the 35 cent share price? 

Small wonder longterm retail shareholders are shuffling their feet and trying not to look like pigeons.


Claridge wrote: Still focused only on the share price Bungee?  

Funny that if you would have entered today the stock price for the first time, you'd sing a much different song and would laud the management.  And wouldn't even have a thought for longtime shareholders.  You're that type of superficial guy. 



___________________

Bunge - (7/25/2019 11:10:50 AM) 

UP

I'm up 1 cent after 6 years.

TLT Theralase Technologies Inc.  0.35 -0.015 (-4.11%)

Woohoo.

I'm rich!

TLT management continues to the BEST!

How they find guys so in tune with long time shareholders and the market is amazing.



Bullboard Posts